Skip to main content

Table 2 List of the studies of Chr1q and/or CHD1L amplification in cancer

From: CHD1L: a novel oncogene

Tumor origin Chr1q/CHD1L Technique used Biological/clinical impact References
Breast Chr1q ( 67%) CGH genetic aberration [6]
Bladder Chr1q ( 54%) CGH Invasive cancer [5]
CHD1L PCR Poor prognosis [31]
Chr1q21-24 CGH + expression Survival genes [26]
Colorectal CHD1L FISH, PCR Oncogene, Poor survival [11]
Esophageal Chr1q CGH Genetic aberration [9]
Fibrosarcoma CHD1L CGH Genetic defect [10]
Liver Chr1q21 CGH Poor prognosis [8]
( 56 ~78%) FISH CHD1L was [12]
Chr1q21 TMA + IHC Sequenced [29]
CHD1L   Poor prognosis  
CHD1L    
Ovarian CHD1L TMA + IHC Metastatic cancer with poor prognosis [30]